1. Introduction – Terbutaline Sulphate, Bromhexine Hydrochloride & Guaiphenesin Syrup:
The Batch Packing Record (BPR) of Terbutaline Sulphate, Bromhexine Hydrochloride & Guaiphenesin Syrup is an essential pharmaceutical documentation system designed to ensure the controlled, consistent, and traceable packing of the finished medicinal product in accordance with Good Manufacturing Practices (GMP). This combination syrup contains Terbutaline Sulphate IP 1.25 mg, Bromhexine Hydrochloride IP 4 mg, and Guaiphenesin IP 50 mg per 5 mL. Terbutaline acts as a bronchodilator, Bromhexine functions as a mucolytic agent, and Guaiphenesin serves as an expectorant. Together, these ingredients help manage respiratory conditions associated with bronchospasm and excessive mucus production. The BPR provides systematic documentation of critical packing activities, including bulk product handover, packaging material dispensing, line clearance, bottle washing, filling, sealing, labelling, inspection, and final shipper packing. It also includes in-process quality control checks such as fill volume verification, sealing integrity, leakage testing, cap perforation inspection, rejection analysis, and printed packaging material reconciliation. The product is packed in 60 mL clear PET bottles with polypropylene caps and printed labels, as specified in the attached record. Proper implementation of the BPR ensures batch traceability, packaging accuracy, accountability of materials, prevention of mix-ups, and compliance with established quality requirements. The completed BPR serves as documented evidence of packing operations and supports Quality Assurance review, batch release decisions, regulatory inspections, and continuous improvement in pharmaceutical packaging operations.
Skip to PDF content2. Flow Diagram – Terbutaline Sulphate, Bromhexine Hydrochloride & Guaiphenesin Syrup:
The flow diagram for the Batch Packing Record (BPR) of Terbutaline Sulphate, Bromhexine Hydrochloride & Guaiphenesin Syrup illustrates the systematic sequence of pharmaceutical packing operations performed under Good Manufacturing Practices (GMP) to ensure product quality, safety, and traceability. The process begins with the handover of approved bulk syrup from the manufacturing department to the packing section, followed by dispensing and verification of packaging materials, including 60 mL PET bottles, polypropylene caps, printed labels, measuring caps, trays, and corrugated boxes.
Before packing activities commence, line clearance is performed to verify equipment cleanliness and removal of previous product materials. The syrup is then filled into bottles using a filling machine, with periodic in-process checks for fill volume. Subsequent operations include cap sealing, leakage testing, labelling, visual inspection, and secondary packing. Critical quality checks monitor sealing integrity, cap perforation, label accuracy, packaging defects, and product identification. Finally, the packed bottles undergo material reconciliation, yield calculation, documentation review, and transfer to bonded stores. Quality Assurance verifies the completed records and applicable quality requirements before finished-product release. The flow diagram provides a clear visual representation of the packing process, helping production and quality personnel maintain consistency, prevent mix-ups, minimize packaging errors, and ensure compliance with approved procedures.
3. Critical Process Parameters (CPP) and Critical Quality Attributes (CQA) for Terbutaline Sulphate, Bromhexine Hydrochloride & Guaiphenesin Syrup (BPR):
The Critical Process Parameters (CPP) and Critical Quality Attributes (CQA) of Terbutaline Sulphate, Bromhexine Hydrochloride & Guaiphenesin Syrup are essential elements of pharmaceutical quality assurance that help ensure product consistency, safety, and compliance with Good Manufacturing Practices (GMP). Critical Process Parameters (CPP) are process variables whose variation may affect critical product quality attributes and therefore require appropriate monitoring or control. Important packing process controls include bulk syrup verification, packaging material dispensing, line clearance, bottle washing, filling volume settings, sealing conditions, labelling accuracy, and packaging operations.
During filling, parameters such as machine speed, fill volume, and nozzle performance are monitored to prevent underfilling, overfilling, and product loss. Sealing operations require control of machine settings and verification of cap integrity to minimize leakage and contamination risks. Critical Quality Attributes (CQA) are the physical, chemical, biological, or microbiological properties that must remain within appropriate limits to ensure the desired product quality. Relevant attributes include syrup appearance, identity, strength, purity, microbiological quality, fill volume, container-closure integrity, and correct product labelling. The Batch Packing Record incorporates in-process checks for fill volume, sealing quality, leakage, cap perforation, labelling, rejection analysis, and packaging material reconciliation. Effective monitoring of process parameters and quality attributes helps minimize packaging defects, prevent product mix-ups, maintain batch traceability, and support consistent finished-product quality.
Note: The illustrated parameters represent potential CPPs and CQAs. Their criticality and acceptance limits must be established through documented risk assessment, process validation, approved specifications, and applicable regulatory requirements.